Cargando…

Induction Fluorouracil-Based Chemotherapy and PET-Adapted Consolidation Chemoradiation with Esophagectomy for High-Risk Gastroesophageal Adenocarcinoma

SIMPLE SUMMARY: Induction chemotherapy followed by PET-adapted consolidation chemoradiotherapy has been ex-plored with success in the clinical trial setting for patients with high-risk gastroesophageal adeno-carcinoma. This study demonstrates that this strategy can be associated with high rate of pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinnamon, Andrew J., Mehta, Rutika, Saeed, Samir, Lauwers, Gregory Y., Palm, Russell F., Frakes, Jessica M., Hoffe, Sarah E., Baldonado, Jobelle J., Fontaine, Jacques P., Pimiento, Jose M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486661/ https://www.ncbi.nlm.nih.gov/pubmed/37686650 http://dx.doi.org/10.3390/cancers15174375

Ejemplares similares

Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status
por: Wood, Anthony C, et al.
Publicado: (2022)

Rectal tumor fragmentation as a response pattern following chemoradiation
por: Mills, Matthew N., et al.
Publicado: (2022)

Factors associated with pathologic complete response following neoadjuvant chemoradiation and esophagectomy for carcinoma of esophagus and gastroesophageal junction
por: Nusrath, Syed, et al.
Publicado: (2022)

Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation?
por: Luu, Carrie, et al.
Publicado: (2017)

Cost‐effectiveness of chemoradiation followed by esophagectomy versus chemoradiation alone in squamous cell carcinoma of the esophagus
por: Salcedo, Jonathan, et al.
Publicado: (2019)

FANCD2 Mutation in a Patient With Early Rectal Cancer Receiving Definitive Chemoradiation
por: McDonald, Jordan, et al.
Publicado: (2021)

History of esophagectomy for cancer of the esophagus and the gastroesophageal junction
por: Lerut, Toni, et al.
Publicado: (2021)

Outcomes of robotic lobectomy for non-small cell lung cancer in a National Cancer Institute-Comprehensive Cancer Center vs. National Cancer Database
por: Baldonado, Jobelle J. A. R., et al.
Publicado: (2023)

Pembrolizumab for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer: an evidence-based review of place in therapy
por: Mehta, Rutika, et al.
Publicado: (2018)

Real-World Molecular Biomarker Testing Patterns and Results for Advanced Gastroesophageal Cancers in the United States
por: Mehta, Rutika, et al.
Publicado: (2023)

Timing of Esophagectomy after Neoadjuvant Chemoradiation Therapy Affects the Incidence of Anastomotic Leaks
por: Roh, Simon, et al.
Publicado: (2019)

Concurrent Chemoradiation With 5-Fluorouracil and Mitomycin in Squamous Cell Carcinoma of the Rectum
por: Sethi, Ashish K
Publicado: (2021)

Reliability and safety of minimally invasive esophagectomy after neoadjuvant chemoradiation: a retrospective study
por: Liu, Guangyuan, et al.
Publicado: (2019)

Prognostication and optimal criteria of circumferential margin involvement for esophageal cancer after chemoradiation and esophagectomy
por: Potdar, Ankit, et al.
Publicado: (2023)

Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
por: Plum, Patrick Sven, et al.
Publicado: (2021)

Role of Esophagectomy after Chemoradiation Therapy in Patients with Locally Advanced Squamous Cell Carcinoma: A Comparative Analysis Stratified by Clinical Response to Chemoradiation Therapy
por: Yu, Jesang, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Venkat, Puja S., et al.
Publicado: (2017)

Anastomotic Leaks following Esophagectomy for Esophageal and Gastroesophageal Junction Cancer: The Key Is the Multidisciplinary Management
por: Ortigão, Raquel, et al.
Publicado: (2021)

Total laparoscopic and thoracoscopic Ivor Lewis esophagectomy after neoadjuvant Chemoradiation with minimal overall and anastomotic complications
por: Merritt, Robert E., et al.
Publicado: (2019)

Residual lymph node disease and mortality following neoadjuvant chemoradiation and curative esophagectomy for distal esophageal adenocarcinoma
por: Kandilis, Apostolos, et al.
Publicado: (2020)

Association between the Preoperative Standard Uptake Value (SUV) and Survival Outcomes after Robotic-Assisted Segmentectomy for Resectable Non-Small Cell Lung Cancer (NSCLC)
por: Aboukheir Aboukheir, Aihab, et al.
Publicado: (2023)

Clinical Profile and Outcome of Postthymectomy versus Non-Thymectomy Myasthenia Gravis Patients in the Philippine General Hospital: A 6-Year Retrospective Study
por: De Roxas, Ranhel C., et al.
Publicado: (2016)

Integration of Consolidation Chemotherapy After Concurrent Chemoradiation in the Treatment of Locally Advanced Uterine Cervical Cancer
por: Haritha, V. S., et al.
Publicado: (2022)

Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC
por: Langberg, Christian Wilhelm, et al.
Publicado: (2023)

Health-related quality of life after gastrectomy, esophagectomy, and combined esophagogastrectomy for gastroesophageal junction adenocarcinoma
por: Kauppila, Joonas H., et al.
Publicado: (2017)

The Value of Paratracheal Lymphadenectomy in Esophagectomy for Adenocarcinoma of the Esophagus or Gastroesophageal Junction: A Systematic Review of the Literature
por: Gantxegi, Amaia, et al.
Publicado: (2021)

Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy
por: Koëter, Marijn, et al.
Publicado: (2015)

Feasibility and Oncological Outcome of Preoperative Chemoradiation With IMRT Dose Intensification for Locally Advanced Esophageal and Gastroesophageal Cancer
por: Innocente, Roberto, et al.
Publicado: (2021)

Incidence and Dosimetric Predictors of Radiation-Induced Gastric Bleeding After Chemoradiation for Esophageal and Gastroesophageal Junction Cancer
por: Montovano, Margaret, et al.
Publicado: (2021)

Preoperative Chemoradiation in Locally Advanced Rectal Cancer: A Comparison of Bolus 5-Fluorouracil/Leucovorin and Capecitabine
por: Yoney, Adnan, et al.
Publicado: (2014)

Phase I Study of Lenvatinib and Capecitabine with External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma
por: Mehta, Rutika, et al.
Publicado: (2022)

Transhiatal versus Left Transthoracic Esophagectomy for Gastroesophageal Junction Cancer; The Impact of Surgical Approach on Postoperative Complications
por: Mir, Mohammad Reza, et al.
Publicado: (2019)

Esophagectomy or Total Gastrectomy for Siewert 2 Gastroesophageal Junction (GEJ) Adenocarcinoma? A Registry-Based Analysis
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

Docetaxel, Cisplatin, and 5‐Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma
por: Fiteni, Frédéric, et al.
Publicado: (2016)

Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer
por: Chau, I, et al.
Publicado: (2003)

Postoperative chemoradiation therapy using high dose cisplatin and fluorouracil for high- and intermediate-risk uterine cervical cancer
por: Miyauchi, Rise, et al.
Publicado: (2017)

Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial
por: Vreugdenhil, M., et al.
Publicado: (2021)

Microarray Analysis of Circular RNA Expression Profile Associated with 5-Fluorouracil-Based Chemoradiation Resistance in Colorectal Cancer Cells
por: Xiong, Wei, et al.
Publicado: (2017)

Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data can enable treatment response prediction in pancreatic cancer
por: Tomaszewski, M. R., et al.
Publicado: (2021)

Consolidation treatment of durvalumab after chemoradiation in real‐world patients with stage III unresectable non‐small cell lung cancer
por: Chu, Chia‐Hsun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gkat6kkosq8dt6ml2v7plbr4sv